"hepatocellular carcinoma" trang 8 - tải miễn phí từ tailieuXANH
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: A prospective cohort study

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: A prospective cohort study
10    54    0
Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study

Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
12    73    0
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: A costeffectiveness analysis

Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: A costeffectiveness analysis
12    70    0
Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway
13    55    0
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma

Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
8    71    0
ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells

ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells
9    38    0
Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection

Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
14    61    0
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma
8    60    0
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
8    55    0
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway

Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
12    51    0
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
10    71    0
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion

Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion
9    50    0
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function
14    50    0
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
11    77    0
Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma

Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma
8    63    0
A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
13    46    0
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
10    51    0
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
8    82    0
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
7    85    0
Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation

Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
12    85    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.